These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 9855174)
1. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers. Scheiman J; Isenberg J Am J Med; 1998 Nov; 105(5A):32S-38S. PubMed ID: 9855174 [TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
3. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression. Lad R; Armstrong D Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432 [TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. Dajani EZ; Agrawal NM J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335 [TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Lazzaroni M; Bianchi Porro G Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362 [TBL] [Abstract][Full Text] [Related]
6. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. Naesdal J; Wilson I Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186 [TBL] [Abstract][Full Text] [Related]
7. [Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs]. Cozzarini W; Rath J; Bauer A; Györög I; Györög M; Prenner M; Trianto T; Maderbacher H; Höller E; Grusch B; Sebesta C Wien Med Wochenschr; 2003; 153(13-14):295-303. PubMed ID: 12924104 [TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. Lee M South Med J; 1995 May; 88(5):507-13. PubMed ID: 7732438 [TBL] [Abstract][Full Text] [Related]
16. Prevention of NSAID-induced GI mucosal injury. Gerritz S; Newton WP J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509 [No Abstract] [Full Text] [Related]
17. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis? Goldstein JL Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893 [TBL] [Abstract][Full Text] [Related]
18. NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis. Stalnikowicz R; Rachmilewitz D J Clin Gastroenterol; 1993 Oct; 17(3):238-43. PubMed ID: 7901267 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of Non-steroidal Anti-inflammatory Drug-induced Peptic Ulcers]. Chu SJ; Yoon KT; Kim JS Korean J Gastroenterol; 2020 Nov; 76(5):232-237. PubMed ID: 33234769 [TBL] [Abstract][Full Text] [Related]
20. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers. Ballinger A Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]